Does MS Cause Muscle Weakness? Types and Treatments

Yes, multiple sclerosis directly causes muscle weakness, and it’s one of the most common symptoms of the disease. Studies estimate that between 52% and 72% of people with MS experience measurable muscle weakness, with force reductions ranging from 16% to 57% compared to people without the condition. The weakness stems from damage to the nervous system, not the muscles themselves, though prolonged inactivity can make things worse over time.

How MS Causes Weakness

MS attacks the protective coating (myelin) that wraps around nerve fibers in the brain and spinal cord. This coating normally allows electrical signals to travel quickly and reliably from your brain to your muscles. When it’s damaged, those signals slow down, arrive weakened, or get blocked entirely. Your muscles are physically capable of contracting, but they aren’t receiving the full instructions from your brain to do so.

If the myelin damage persists, the underlying nerve fibers themselves begin to degenerate. This is a more permanent form of injury. While early signal disruptions can sometimes improve as inflammation subsides or the body partially repairs the myelin, nerve fiber loss is irreversible. This progression is why weakness in MS can worsen over time and why early treatment to reduce nerve damage matters so much.

Primary Weakness vs. Secondary Weakness

There are two layers to muscle weakness in MS, and understanding the difference matters for managing it. Primary weakness comes directly from impaired nerve signaling. Your brain can’t fully activate the muscle, so even with maximal effort, the muscle produces less force than it should. This is the core neurological problem.

Secondary weakness develops on top of that. When nerve damage makes movement harder, you naturally move less. That disuse causes muscles to shrink, shift toward less endurance-oriented fiber types, and lose some of their energy-producing capacity. These changes are similar to what happens to anyone who becomes sedentary, but in MS they compound the existing neurological deficit. The good news: secondary weakness is partially reversible with exercise, even though primary weakness may not be.

Which Muscles Are Most Affected

MS-related weakness most commonly shows up in the legs, particularly the muscles around the knees and ankles. Research using strength testing and imaging has found that people with MS often develop noticeable asymmetry in their knee extensors (the muscles that straighten your leg), knee flexors (the muscles that bend your knee), and the muscles controlling ankle movement. The hip flexors, which lift your thigh when walking, also tend to work harder than normal, suggesting they compensate for weakness elsewhere.

This pattern explains why walking problems are so central to the MS experience. Weakness in these lower-limb muscle groups affects balance, stride length, and endurance on your feet. Upper body weakness also occurs but is typically less prominent in early and moderate stages of the disease.

Weakness, Fatigue, and Fatigability Are Different

People with MS often describe feeling “weak” when what they’re actually experiencing is one of three distinct problems, each with different causes and solutions.

  • Muscle weakness is a reduced ability to generate maximum force, even when fully rested. You try to grip something or push off the ground and the strength simply isn’t there.
  • Motor fatigability is a decline in force output during sustained or repeated activity. You might start a task at near-normal strength but lose power quickly. Research shows fatigability can occur independently of baseline weakness, meaning someone with normal resting strength can still fatigue abnormally fast.
  • MS-related fatigue is a subjective sense of exhaustion and increased effort that’s measured by how you feel, not by what your muscles produce. It’s the most commonly reported MS symptom but does not always correlate with actual changes in muscle performance.

These three problems frequently overlap, which makes them easy to confuse. But recognizing which one is dominant in your case helps guide the right approach, whether that’s strength training, pacing strategies, or fatigue management techniques.

How Spasticity Complicates the Picture

Spasticity, the involuntary tightness and stiffness in muscles, affects 60% to 84% of people with MS. It can mask underlying weakness in a counterintuitive way: a leg might feel stiff and rigid rather than weak, even though the muscles can’t generate normal voluntary force. The stiffness comes from abnormal reflex activity, not from the muscles being strong.

In some cases, spasticity actually provides a functional benefit. Stiff legs can sometimes support body weight during standing or walking better than truly flaccid, weak ones. But it also causes pain, limits range of motion, and interferes with coordinated movement. Treating spasticity without also addressing the weakness underneath it requires careful balance, because reducing tone too aggressively can unmask weakness that makes walking even harder.

Exercise for MS-Related Weakness

Resistance training is one of the most effective tools for managing MS-related weakness, and clinical trials consistently show it does not trigger MS relapses. Current guidelines from the National MS Society recommend building toward at least 150 minutes per week of exercise or physical activity, adjusted for individual capacity and symptoms.

More specifically, clinical practice guidelines recommend resistance training at least twice per week targeting major muscle groups, with 2 to 3 sets of 8 to 12 repetitions per exercise. This can include weightlifting, resistance bands, or bodyweight exercises. Moderate-intensity aerobic exercise like walking, cycling, or swimming for 20 to 40 minutes, three times per week, complements strength work by improving overall functional capacity. Flexibility and stretching exercises help manage spasticity and maintain joint range of motion.

Exercise can temporarily worsen existing symptoms like weakness, tingling, or visual disturbances, particularly when body temperature rises. This is a well-known phenomenon in MS, not a sign of disease progression. Cooling strategies like fans, cooling vests, or exercising in water kept around 84°F can minimize it. Working with a rehabilitation therapist, at least initially, helps tailor a program to your specific pattern of weakness and ensures exercises are performed safely.

Medication That Targets Motor Function

One medication specifically targets the nerve signaling problem behind MS weakness. It works by blocking potassium channels on demyelinated nerve fibers, which helps restore electrical signal transmission along damaged nerves. In clinical studies, people taking this medication walked significantly faster, covered more distance in timed walking tests, and showed improved balance scores compared to periods when they were off the drug. Walking speed improved by about 0.36 feet per second, and walking distance in a two-minute test increased by over 25 feet. These improvements are modest but meaningful for daily mobility.

Disease-modifying therapies, while not directly treating weakness, aim to reduce the nerve damage that causes it. By lowering the frequency and severity of MS relapses and slowing the accumulation of disability, these treatments help preserve motor function over the long term. The earlier they’re started, the more nerve function they tend to protect.

How Weakness Is Assessed

Clinicians typically evaluate MS-related weakness using manual muscle testing, a hands-on exam where you push against resistance while the examiner rates your strength on a 0 to 5 scale. It’s quick and practical but has limitations: it’s only objective at the lower end of the scale, and subtle weakness at grades 4 and 5 depends heavily on the tester’s judgment. Early or mild weakness can go undetected with this method alone.

The Expanded Disability Status Scale is a broader assessment that tracks overall disability progression, including motor function. Scores from 0 to 3.5 indicate mild disability, while 4.0 to 5.5 reflects moderate disability, a range where walking limitations typically become more apparent. For people who feel weaker but keep getting normal results on basic strength tests, more sensitive tools like isokinetic dynamometers or timed functional tests can capture deficits that manual testing misses.